Help for diagnosing and treating chronic valvular heart disease in dogs.
Untitled Document
“The guidelines spell out areas of unanimous current consensus that provide a practical guide for your day-to-day practice (e.g. standard therapy for dogs with clinical signs of heart failure caused by mitral valve insufficiency should ideally include a combination of furosemide, pimobendan, and an angiotensin-converting enzyme inhibitor).”
-Bruce Keene, DVM, MSc, DACVIM (cardiology)
From Leading Off: Guidelines make managing canine heart disease more clear-cut
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Torsemide for canine CHF: Emerging evidence and clinical benefits
June 5th 2025William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Read More